期刊
NATURE CLINICAL PRACTICE ONCOLOGY
卷 2, 期 9, 页码 466-472出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ncponc0287
关键词
meta-analysis; prognosis; prognostic factor; systematic review
类别
Prognastic markers can help to identify patients at different degrees of risk for specific outcomes, facilitate treatment choice, and aid patient counselling. Compared with other research designs, prognastic studies have been relatively neglected in the broad efforts to improve the quality of medical research, despite their ubiquity. Large protocol-driven, prospective studies are the ideal, with clear, unbiased reporting of methods used and the results obtained. Unfortunately, published prognastic studies rarely meet such standards, and in this article we discuss their main problems and how they casn be improved. In particular, an evidence-based approach to prognastic markers is required, as it is usually difficult to ascertain the benefit of a marker from single studies and a clear view is only likely to emerge from looking across multiple studies. Current systematic reviews and meta-analyses often fail to provide clear evidence-based answers, and rather only draw attention to the paucity of good-quality evidence. Prospectively planned pooled analyses of high-quality studies, along with general availability of individual patient data and adherence to reporting guidelines, would help alleviate many of these problems.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据